Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wagner, Andrew
Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Andrew Wagner
Favorite
Wagner, Michael
University of Washington/Fred Hutch Cancer Center
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Michael Wagner
Favorite
Wahba, Mona
PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Mona Wahba
Favorite
Wahlig, Brian
Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Brian Wahlig
Favorite
Walker, Deandra
Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Deandra Walker
Favorite
Walters, Ian
Intensity Therapeutics
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Ian Walters
Favorite
Wang, Jiping
TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jiping Wang
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Jiping Wang
Favorite
Wang, Qing
Department of Pathology, Institut Claudius Régaud, IUCT-Oncopole, Toulouse,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Qing Wang
Favorite
Wang, Ruoxi
Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Ruoxi Wang
Favorite
Wang, Wei-Lien
The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Wei-Lien Wang
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Wei-Lien Wang
Favorite
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Wei-Lien Wang
Favorite
Wang, Xia
GeneHome, Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Xia Wang
Favorite
Wason, James
Newcastle University
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
James Wason
Favorite
Watowich, Stepahnie
MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Stepahnie Watowich
Favorite
Watson, Sarah
Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Sarah Watson
Favorite
Watt, Tanya
University of Texas Southwestern Medical Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Tanya Watt
Favorite
Weetall, Marla
PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Marla Weetall
Favorite
Weise, Amy
Barbara Ann Karmanos Cancer Institute, Karmanos Cancer Institute
Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Amy Weise
Favorite
Weiss, Aaron
Maine Cancer Program
Paper 50 - OUTCOMES OF ADOLESCENTS AND YOUNG ADULTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE SARCOMA COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Aaron Weiss
Favorite
Wessel, Lauren
University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Lauren Wessel
Favorite
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Lauren Wessel
Favorite
Westermann, Frank
Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Frank Westermann
Favorite
West, Robert
Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Robert West
Favorite
Westwood, Andrew
Euro Ewing Consortium
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Andrew Westwood
Favorite
Wexler, Leonard
Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Leonard Wexler
Favorite
Whalen, Giles Francis
University of Massachusetts Memorial Medical Center,
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Giles Francis Whalen
Favorite
Wheatley, Keith
University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Keith Wheatley
Favorite
Whelan, Jeremy
University College London Hospitals
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Jeremy Whelan
Favorite
White, Lawrence
Toronto General Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Lawrence White
Favorite
Widemann, Brigitte
National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Brigitte Widemann
Favorite
Wijers-Koster, Pauline
Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Pauline Wijers-Koster
Favorite
Wilky, Breelyn
University of Colorado
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Breelyn Wilky
Favorite
Paper 78 - A MULTICENTER RETROSPECTIVE EVALUATION OF THE FEASIBILITY AND RADIOLOGICAL AND CLINICAL OUTCOMES OF CRYO-ABLATION THERAPY FOR EXTRA-ABDOMINAL DESMOID
Breelyn Wilky
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Breelyn Wilky
Favorite
Williams, Dennis
Adaptimmune
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Dennis Williams
Favorite
Williams, Kyle
Univerysity of Minnesota
Paper 29 - ALTERED EPIGENETIC HOMEOSTASIS YIELDS THERAPEUTIC VULNERABILITIES IN NEUROFIBROMATOSIS TYPE 1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Kyle Williams
Favorite
Windsor, Rachael
Sarcoma Department, University College Hospital, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Rachael Windsor
Favorite
Winstanley, Mark
Starship Children's Hospital
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Mark Winstanley
Favorite
Witt, Russell
University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Russell Witt
Favorite
Wolters, Pamela
National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Pamela Wolters
Favorite
Wong, Marie
Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Marie Wong
Favorite
Wong, Ralph
Cancer Care Manitoba
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Ralph Wong
Favorite
Wood, Kris
Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Kris Wood
Favorite
Wooldridge, Adam
Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Adam Wooldridge
Favorite
Wozniak, Agnieszka
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
Mentorship Session 3: Biobanking and Correlative Science: How to Establish and Learn about Rare Tumor Biology
Agnieszka Wozniak
Favorite
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Agnieszka Wozniak
Favorite
Wu, Chia-Chin
The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Chia-Chin Wu
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Chia-Chin Wu
Favorite
Wunder, Jay
Mount Sinai Hospital; University of Toronto
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Jay Wunder
Favorite
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Jay Wunder
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Jay Wunder
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Jay Wunder
Favorite
Wunker, Claire
Saint Louis University
Paper 32 - ESTABLISHMENT OF HIGH-GRADE SOFT TISSUE SARCOMA METASTATIC DISEASE MURINE MODELS
Claire Wunker
Favorite
Wurtz, Lawrence
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Lawrence Wurtz
Favorite
Back to Top
